.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 5,707,986

« Back to Dashboard

Details for Patent: 5,707,986

Title: Angiographic method using green porphyrins in primate eyes
Abstract:An angiographic method to observe the condition of blood vessels, including neovasculature in the eyes of living primates using green porphyrins and light at a wavelength of 550-700 nm to effect fluorescence is disclosed.
Inventor(s): Miller; Joan W. (Boston, MA), Young; Lucy H.Y. (Boston, MA), Gragoudas; Evangelos S. (Boston, MA)
Assignee:
Filing Date:Mar 14, 1994
Application Number:08/209,473
Claims:1. An angiographic method to observe the condition of blood vessels, including neovasculature in the eye of an intact living primate, which method comprises:

a. administering to said primate comprising at least one eye for which said observation is desired and containing said neovasculature an amount of green porphyrin which will provide an observable amount of green porphyrin in the blood vessels and neovasculature of said eye;

b. permitting sufficient time to elapse so that an observable amount of said green porphyrin resides in the blood vessels and neovasculature of the eye; and

c. applying light of a wavelength in the range of about 550-700 nm to the eye so as to effect fluorescence of the green porphyrin; and

d. detecting said fluorescence with a suitable camera.

2. The method of claim 1 wherein said green porphyrin is a BPD.

3. The method of claim 2 wherein said BPD is BPD-MA.

4. The method of claim 1 wherein said green porphyrin is complexed with low-density lipoprotein.

5. The method of claim 1 wherein said green porphyrin is contained in a liposomal preparation.

6. The method of claim 3 wherein said BPD-MA is contained in a liposomal preparation.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc